Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study

The American Journal of Gastroenterology
Ivo C DitahMichael Charlton

Abstract

Identifying barriers to access to hepatitis C virus (HCV) treatment among screen detected subjects is critical for any public health strategy aimed at controlling HCV infection in the general population. Data from the National Health and Nutrition Examination Survey HCV Follow-up study from 2001 to 2010 were used. Participants who tested positive for HCV were sent a letter informing them of their test results and advised to pursue further evaluation. Information on HCV transmission and its potential complications was also provided to all positive participants. These subjects were recontacted 6 months after notification to determine what action they had taken regarding the positive result. Of 38,025 participants, 502 tested positive for HCV infection, giving a prevalence of 1.3% (95% confidence interval (CI) 0.8%, 1.8%). A total of 205 subjects participated in the 6-month follow-up interview. Those who could not be reached were more likely to be less educated, injecting drugs, and not to have health insurance. Half (50.2%) of the positive individuals were not aware of their status before notification. A total of 166 (81%) had pursued further evaluation. Only 18 (26.9%) received therapy. The main reason for not receiving treatmen...Continue Reading

References

Feb 1, 1991·Investigational New Drugs·K DhingraJ U Gutterman
Nov 18, 1989·Lancet·P J Flegg
Sep 7, 2002·The American Journal of Emergency Medicine·Judith C BrillmanJoshua L Jacobs
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Leonard B Seeff
Apr 12, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Gary L DavisDaniel M Rosenberg
Feb 7, 2007·Public Health Reports·Holly HaganRichard S Garfein
Apr 7, 2007·Current Opinion in Gastroenterology·Jessica Tan, Anna Sf Lok
Jun 7, 2007·World Journal of Gastroenterology : WJG·Miriam J Alter
Oct 17, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jennifer A TanSammy Saab
Oct 14, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael L VolkAnna S F Lok
Dec 17, 2009·American Journal of Public Health·C Kent MartinJohn J Hagan
May 26, 2010·Journal of Viral Hepatitis·W N SouthernA H Litwin
Aug 27, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·David B ReinSarah B Lesesne
Jul 13, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Eric ChakSammy Saab
Nov 8, 2011·Annals of Internal Medicine·David B ReinCindy M Weinbaum
Jan 4, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maxine M DennistonRuth B Jiles
Jun 9, 2012·The Medical Journal of Australia·Margaret E HellardNatasha K Martin
Aug 10, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philip R SpradlingUNKNOWN Chronic Hepatitis Cohort Study Investigators
May 17, 2013·The New England Journal of Medicine·T Jake Liang, Marc G Ghany
Jun 26, 2013·Annals of Internal Medicine·Quyen Ngo-MetzgerRonald O Valdiserri
Jun 26, 2013·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Natasha K MartinPeter Vickerman
Oct 31, 2013·Journal of Viral Hepatitis·N H AfdhalUNKNOWN New Paradigm of HCV Therapy Meeting Participants
Nov 19, 2013·Trends in Microbiology·Liesl M HaganRaymond F Schinazi

❮ Previous
Next ❯

Citations

Dec 3, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David P DurhamJeffrey P Townsend
Jun 5, 2019·International Journal of STD & AIDS·Jimmy MaRachel M Presti
Jun 25, 2019·PloS One·Matteo BrezziUNKNOWN Swiss Hepatitis C Cohort Study
Nov 7, 2017·Journal of Viral Hepatitis·A MaaroufiK Razavi-Shearer
Jun 30, 2018·Journal of Translational Medicine·Alexandra DeBose-ScarlettEmmanuel Thomas
Oct 28, 2016·World Journal of Gastroenterology : WJG·Susan L StewartMoon S Chen
May 12, 2021·Computers in Biology and Medicine·Jasmine Ye NakayamaVicki Stover Hertzberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.